Blepharospasm as a Manifestation of Peak of Dose Dyskinesia in Parkinson Disease. [electronic resource]
- Clinical neuropharmacology
- 14-16 p. digital
Publication Type: Case Reports; Journal Article
1537-162X
10.1097/WNF.0000000000000316 doi
Aged Antiparkinson Agents--administration & dosage Blepharospasm--chemically induced Botulinum Toxins, Type A--adverse effects Carbidopa--adverse effects Drug Combinations Dyskinesias--drug therapy Humans Levodopa--administration & dosage Male Middle Aged Parkinson Disease--drug therapy